SciBase: New German study shows Nevisense significantly improves dermatologists clinical decisions

STOCKHOLM, May 22, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders announced today that a new

Related Keywords

Stockholm ,Sweden ,Germany ,German ,Pia Renaudin ,Prnewswire Scibase Holding Ab ,Karolinska Institute ,Nasdaq First North Growth Market ,German Reader ,Ihr Portfolio ,